Guangdong Lifestrong Pharmacy Co., Ltd. (SHE:301111)

SHE:301111 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	104.93	159.1	131.11	179.21	485.35	108.13
Short-Term Investments	128.28	128.25	141.14	190.97	20.42	-
Trading Asset Securities	74.85	34.81	72.86	81.32	48.04	26.29
Cash & Short-Term Investments	308.06	322.16	345.11	451.51	553.81	134.42
Cash Growth	-8.84%	-6.65%	-23.57%	-18.47%	312.00%	32.01%
Accounts Receivable	85.6	85.23	74	71.01	97.57	81.3
Other Receivables	4.17	2.69	3.34	2.01	1.94	3.89
Receivables	89.77	87.91	77.34	73.02	99.51	85.19
Inventory	98.93	90.13	83.43	70.69	51.91	55.26
Prepaid Expenses	-	0	-	-	-	-
Other Current Assets	15.2	14.99	3.78	5.73	3.62	8.17
Total Current Assets	511.97	515.2	509.66	600.95	708.84	283.04
Property, Plant & Equipment	104.57	115.24	58.59	55.94	74.55	91.48
Long-Term Investments	191.69	219.41	238.08	181.28	33.47	-
Goodwill	10.45	7.32	-	-	-	-
Other Intangible Assets	29.55	29.88	30.18	7.83	7.89	8.09
Long-Term Deferred Tax Assets	13.19	13.91	8.51	8.52	1.22	1.16
Long-Term Deferred Charges	28.47	28.71	0.4	-	-	-
Other Long-Term Assets	30.64	3.49	10.13	2.56	0.23	-
Total Assets	920.51	933.17	855.54	857.07	826.2	383.78
Accounts Payable	56.82	56	34.87	29.04	37.59	26.2
Accrued Expenses	5.63	12.71	11.4	17.25	9.38	9.82
Current Portion of Leases	0.88	1.29	3.87	0.16	0.93	-
Current Income Taxes Payable	3.27	1.29	0.2	9.85	5.09	0.3
Current Unearned Revenue	12.83	12.44	5.39	26.88	5.66	4.81
Other Current Liabilities	11.81	11.13	10.24	10.19	7.44	6.95
Total Current Liabilities	91.23	94.85	65.97	93.36	66.08	48.08
Long-Term Leases	62.58	70.86	10.09	-	0.16	-
Long-Term Unearned Revenue	0.58	0.7	1.28	5.04	7.45	9.21
Long-Term Deferred Tax Liabilities	-	-	-	-	1.66	3.07
Total Liabilities	154.39	166.42	77.33	98.39	75.34	60.37
Common Stock	160	160	160	160	160	120
Additional Paid-In Capital	406.94	406.94	406.94	406.94	406.94	76.67
Retained Earnings	193.96	197.4	209.23	191.73	183.91	126.73
Total Common Equity	760.9	764.34	776.17	758.67	750.85	323.41
Minority Interest	5.22	2.41	2.03	-0	-	-
Shareholders' Equity	766.11	766.75	778.21	758.67	750.85	323.41
Total Liabilities & Equity	920.51	933.17	855.54	857.07	826.2	383.78
Total Debt	63.46	72.15	13.95	0.16	1.09	-
Net Cash (Debt)	244.61	250.01	331.15	451.35	552.72	134.42
Net Cash Growth	-24.54%	-24.50%	-26.63%	-18.34%	311.19%	32.01%
Net Cash Per Share	1.75	1.80	2.08	2.84	4.64	1.12
Filing Date Shares Outstanding	160	160	160	160	160	120
Total Common Shares Outstanding	160	160	160	160	160	120
Working Capital	420.73	420.34	443.69	507.59	642.77	234.96
Book Value Per Share	4.76	4.78	4.85	4.74	4.69	2.70
Tangible Book Value	720.9	727.13	745.99	750.85	742.96	315.31
Tangible Book Value Per Share	4.51	4.54	4.66	4.69	4.64	2.63
Buildings	-	76.38	68.76	74.73	79.72	80.77
Machinery	-	86.7	78.07	78.59	93.14	99.72
Construction In Progress	-	-	0.72	0.72	-	-

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.